© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Securitization People and Markets

More articles

More articles

  • Strong Capital Management is reorganizing its fixed-income investment team after the recent departures of Ashok Bhatia, Thomas Sontag and John Bonnell, three of its portfolio managers.
  • A bank meeting is scheduled for this Wednesday to launch syndication of a $335 million facility backing J.W. Child Associates' acquisition of fruit drink businesses Sunny Delight and Punica from The Proctor & Gamble Co.
  • Wachovia Securities is beginning to add a high-yield sales department to its New York office. The firm recently hired Oscar Anderson as its first high-yield salesman in the Big Apple.
  • Wachovia Securities and J.P. Morgan flexed pricing up 25 basis points to LIBOR plus 3% on Western Wireless' seven-year, $1 billion "B" loan.
  • Syndication is said to be going well for The Anschutz Co.'s and Oaktree Capital Management's $1.75 billion recapitalization of Regal Cinemas Corp., despite some concerns over the massive size of the dividend.
  • Structural tweaks are expected as syndication wraps up on wholesale used-vehicle auctioneer ADESA's $500 million facility.
  • Barclays Capital has recently hired two new saleswomen for its investment-grade sales department. Amy Levenson and Kelly Saltzgaber start soon in v.p. roles; both join from Goldman Sachs, where they were directors in investment-grade sales.
  • Cryan is a high-yield portfolio manager at Evergreen in Boston. He is the lead manager of the $600 million Evergreen Select High-Yield Bond Fund, which is part of $5 billion in assets run by the firm.
  • Credit Suisse First Boston and Morgan Stanley have been working to persuade investors to buy into WellCare Health Plans' new credit facility, trotting out Morgan's top healthcare analyst and jacking up pricing.